Seres Therapeutics shares are lower higher after the company entered a memorandum of understanding with Nestlé Health Science for the sale of its VOWST assets. The stock initially traded higher, but it has since reversed.
Portfolio Pulse from Benzinga Newsdesk
Seres Therapeutics shares are experiencing volatility after the company entered a memorandum of understanding with Nestlé Health Science for the sale of its VOWST assets. The stock initially traded higher but has since reversed.
June 06, 2024 | 4:52 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Seres Therapeutics shares are volatile following a memorandum of understanding with Nestlé Health Science for the sale of its VOWST assets. The stock initially rose but has since reversed.
The news of the memorandum of understanding with Nestlé Health Science initially caused Seres Therapeutics' stock to rise, indicating positive investor sentiment. However, the subsequent reversal suggests uncertainty or profit-taking. The short-term impact is neutral as the market digests the news.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100